"MART-1 Antigen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A melanosome-specific protein that plays a role in the expression, stability, trafficking, and processing of GP100 MELANOMA ANTIGEN, which is critical to the formation of Stage II MELANOSOMES. The protein is used as an antigen marker for MELANOMA cells.
| Descriptor ID |
D058965
|
| MeSH Number(s) |
D12.776.624.301.750 D23.050.285.439.750
|
| Concept/Terms |
MART-1 Antigen- MART-1 Antigen
- Antigen, MART-1
- MART 1 Antigen
- MART1 Antigens
- Antigens, MART1
- MelanA
- Melanoma Antigen Recognized by T-Cells 1
- Melanoma Antigen Recognized by T Cells 1
- MART1 Antigen
- Antigen, MART1
- Melan-A
- Melan A
|
Below are MeSH descriptors whose meaning is more general than "MART-1 Antigen".
Below are MeSH descriptors whose meaning is more specific than "MART-1 Antigen".
This graph shows the total number of publications written about "MART-1 Antigen" by people in this website by year, and whether "MART-1 Antigen" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 2 | 2 |
| 2008 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "MART-1 Antigen" by people in Profiles.
-
Muzumdar S, Argraves M, Kristjansson A, Ferenczi K, Dadras SS. A quantitative comparison between SOX10 and MART-1 immunostaining to detect melanocytic hyperplasia in chronically sun-damaged skin. J Cutan Pathol. 2018 Apr; 45(4):263-268.
-
Zand S, Buzney E, Duncan LM, Dadras SS. Heterogeneity of Metastatic Melanoma: ?Correlation of MITF With Its Transcriptional Targets MLSN1, PEDF, HMB-45, and MART-1. Am J Clin Pathol. 2016 Sep; 146(3):353-60.
-
Pierce BG, Hellman LM, Hossain M, Singh NK, Vander Kooi CW, Weng Z, Baker BM. Computational design of the affinity and specificity of a therapeutic T cell receptor. PLoS Comput Biol. 2014 Feb; 10(2):e1003478.
-
Chakraborty NG, Yadav M, Dadras SS, Singh P, Chhabra A, Feinn R, Kerr PE, Grant-Kels JM, Mukherji B, Hegde UP. Analyses of T cell-mediated immune response to a human melanoma-associated antigen by the young and the elderly. Hum Immunol. 2013 May; 74(5):640-7.
-
Trevi?o-Villarreal JH, Cotanche DA, Sep?lveda R, Bortoni ME, Manneberg O, Udagawa T, Rogers RA. Host-derived pericytes and Sca-1+ cells predominate in the MART-1- stroma fraction of experimentally induced melanoma. J Histochem Cytochem. 2011 Dec; 59(12):1060-75.
-
Robbins PF, Li YF, El-Gamil M, Zhao Y, Wargo JA, Zheng Z, Xu H, Morgan RA, Feldman SA, Johnson LA, Bennett AD, Dunn SM, Mahon TM, Jakobsen BK, Rosenberg SA. Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions. J Immunol. 2008 May 01; 180(9):6116-31.
-
Ward JR, Brady SP, Tada H, Levin NA. Pigmented epithelioid melanocytoma. Int J Dermatol. 2006 Dec; 45(12):1403-5.
-
Appay V, Jandus C, Voelter V, Reynard S, Coupland SE, Rimoldi D, Lienard D, Guillaume P, Krieg AM, Cerottini JC, Romero P, Leyvraz S, Rufer N, Speiser DE. New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site. J Immunol. 2006 Aug 01; 177(3):1670-8.
-
Speiser DE, Li?nard D, Rufer N, Rubio-Godoy V, Rimoldi D, Lejeune F, Krieg AM, Cerottini JC, Romero P. Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909. J Clin Invest. 2005 Mar; 115(3):739-46.